JPH11314955A - Antibacterial artificial marble - Google Patents
Antibacterial artificial marbleInfo
- Publication number
- JPH11314955A JPH11314955A JP14059198A JP14059198A JPH11314955A JP H11314955 A JPH11314955 A JP H11314955A JP 14059198 A JP14059198 A JP 14059198A JP 14059198 A JP14059198 A JP 14059198A JP H11314955 A JPH11314955 A JP H11314955A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- antibacterial agent
- artificial marble
- mol
- glass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B14/00—Use of inorganic materials as fillers, e.g. pigments, for mortars, concrete or artificial stone; Treatment of inorganic materials specially adapted to enhance their filling properties in mortars, concrete or artificial stone
- C04B14/02—Granular materials, e.g. microballoons
- C04B14/04—Silica-rich materials; Silicates
- C04B14/22—Glass ; Devitrified glass
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B26/00—Compositions of mortars, concrete or artificial stone, containing only organic binders, e.g. polymer or resin concrete
- C04B26/02—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
- C04B2103/60—Agents for protection against chemical, physical or biological attack
- C04B2103/67—Biocides
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00965—Uses not provided for elsewhere in C04B2111/00 for household applications, e.g. use of materials as cooking ware
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/54—Substitutes for natural stone, artistic materials or the like
- C04B2111/542—Artificial natural stone
- C04B2111/545—Artificial marble
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Organic Chemistry (AREA)
- Civil Engineering (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Glass Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
(57)【要約】
【課題】熱硬化性樹脂を主成分とする人工大理石におい
て、加工時、保存時及び使用時に経時的に変色が極めて
少なく、安定して抗菌効果を示す抗菌性人工大理石を提
供する。
【解決手段】ZnOを50〜80モル%、B2O3および
/またはP2O5を20〜50モル%含有し、アルカリ金
属酸化物の含有割合が0〜1モル%であるガラスを有効
成分とする抗菌剤及び熱硬化性樹脂からなることを特徴
とする抗菌性人工大理石。(57) [Problem] An antibacterial artificial marble mainly composed of a thermosetting resin, which exhibits extremely little discoloration over time during processing, storage and use, and exhibits a stable antibacterial effect. provide. A ZnO 50 to 80 mole%, B 2 O 3 and / or P 2 O 5 containing 20 to 50 mol%, the effective glass content of alkali metal oxides is 0-1 mol% An antibacterial artificial marble comprising an antibacterial agent and a thermosetting resin as components.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、キッチンカウンタ
ー、洗面台、トイレ用品、バス用品等に用いられる抗菌
性人工大理石に関する。更に詳しくは、熱硬化性樹脂を
主成分とする人工大理石において、加工時、保存時及び
使用時に経時的に変色が極めて少なく、安定して抗菌効
果を示す抗菌性を付与させた抗菌性人工大理石に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial artificial marble used for kitchen counters, sinks, toilet articles, bath articles and the like. More specifically, in an artificial marble mainly composed of a thermosetting resin, there is extremely little discoloration over time during processing, storage and use, and an antibacterial artificial marble imparted with an antibacterial property showing a stable antibacterial effect. About.
【0002】[0002]
【従来の技術】人工大理石は、耐熱性、耐水性、耐摩耗
性などが優れるため、キッチンカウンター、洗面台、ト
イレ用品、バス用品等に広く用いられている。これら用
途はほとんどが水周りで使用されるため細菌や黴が繁殖
しやすい条件となっている。特に不特定多数の人たちが
使用する病院、学校、公共施設等では、メチシリン耐性
黄色ブドウ球菌(MRSA)の院内感染、大腸菌O−1
57による集団食中毒等の問題があり、人工大理石の抗
菌化が強く望まれている。2. Description of the Related Art Artificial marble has been widely used for kitchen counters, wash basins, toilet articles, bath articles, etc. because of its excellent heat resistance, water resistance, wear resistance and the like. Most of these uses are used around water, so that bacteria and molds are easily propagated. Particularly in hospitals, schools, public facilities, etc. used by unspecified number of people, hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli O-1
Therefore, artificial marble has been strongly antibacterial.
【0003】これらの問題を解決するため、抗菌剤を人
工大理石に添加したり表面層に塗布する試みがなされて
いる。抗菌剤は有機系抗菌剤と無機系抗菌剤に大別でき
るが、前者は安全性、腐食性、抗菌効果の持続性に疑問
がある。一方、無機系抗菌剤は安全性、腐食性、効果の
持続性に優れる。しかし、無機系抗菌剤の大部分は、抗
菌効果を有する銀を含有するものが大部分であるため、
加工時、保存時あるいは使用時に経時的に変色が起こる
という問題がある。[0003] In order to solve these problems, attempts have been made to add an antibacterial agent to artificial marble or to apply it to a surface layer. Antibacterial agents can be roughly classified into organic antibacterial agents and inorganic antibacterial agents, but the former has questions about safety, corrosiveness, and sustainability of antibacterial effects. On the other hand, inorganic antibacterial agents are excellent in safety, corrosiveness and persistence of effects. However, most of inorganic antibacterial agents contain silver having antibacterial effect,
There is a problem that discoloration occurs over time during processing, storage, or use.
【0004】人工大理石は、水、熱水、各種食材、各種
洗浄剤、熱等にさらされる機会が多いため、非常に変色
が起こりやすい。変色を防止するため、特定担体に銀イ
オンを担持させたを抗菌剤を使用する方法があるが、銀
を有しているいる以上、変色を十分に抑制することが出
来ない。さらに、抗菌剤そのものをマイクロカプセル化
する方法も提案されているが、抗菌効果が低下するとい
う問題がある。Since artificial marble is frequently exposed to water, hot water, various foodstuffs, various cleaning agents, heat, and the like, discoloration is very likely to occur. In order to prevent discoloration, there is a method of using an antibacterial agent in which silver ions are supported on a specific carrier, but discoloration cannot be sufficiently suppressed as long as silver is present. Further, a method of microencapsulating the antibacterial agent itself has been proposed, but there is a problem that the antibacterial effect is reduced.
【0005】また、銀を含まない抗菌剤として、亜鉛を
含有する抗菌剤用ガラスが特開平7−257938号が
提案されている。この抗菌剤用ガラスは、溶出する亜鉛
により抗菌効果を発現させるものであるため、初期の抗
菌性は高いが、抗菌効果の持続性が十分ではない。更に
耐水性が低いため、これを添加した人工大理石は温水に
より白化するという問題がある。As an antibacterial agent containing no silver, JP-A-7-257938 has proposed a glass for an antibacterial agent containing zinc. Since the antibacterial glass exhibits an antibacterial effect due to the eluted zinc, the antibacterial effect is high in the initial stage, but the antibacterial effect is not sufficiently maintained. Further, since the water resistance is low, there is a problem that artificial marble to which this is added is whitened by warm water.
【0006】[0006]
【発明が解決しようとする課題】本発明は、キッチンカ
ウンター、洗面台、トイレ用品、バス用品等に用いられ
る熱硬化性樹脂を主成分とする人工大理石において、加
工時、保存時及び使用時に経時的に変色が極めて少な
く、安定して抗菌効果を示す抗菌性人工大理石を提供す
ることを課題とするものである。SUMMARY OF THE INVENTION The present invention relates to an artificial marble mainly composed of a thermosetting resin used for kitchen counters, wash basins, toilet articles, bath articles, etc., which is used for processing, storage and use over time. It is an object of the present invention to provide an antibacterial artificial marble which shows extremely little discoloration and a stable antibacterial effect.
【0007】[0007]
【課題を解決するための手段】本発明者らは、上記の課
題を解決するために鋭意検討した結果、ZnOを極めて
高濃度で含有させ、逆にアルカリ金属酸化物の含有割合
を極めて低濃度とした特定のガラス質抗菌剤を熱硬化性
樹脂に含有させた人工大理石は、上記課題を解決した極
めて優れたものであることを見出し、本発明を完成し
た。即ち、本発明は、ZnOを50〜80モル%、B2
O3および/またはP2O5を20〜50モル%含有し、
アルカリ金属酸化物の含有割合が0〜1モル%であるガ
ラスを有効成分とする抗菌剤及び熱硬化性樹脂からなる
ことを特徴とする抗菌性人工大理石である。Means for Solving the Problems The inventors of the present invention have made intensive studies to solve the above-mentioned problems, and have found that ZnO is contained at a very high concentration and the content ratio of the alkali metal oxide is extremely low. The present inventors have found that an artificial marble in which a specific glassy antibacterial agent is contained in a thermosetting resin is an excellent one that has solved the above problems, and has completed the present invention. That is, the present invention is 50 to 80 mol% of ZnO, B 2
O 3 and / or P 2 O 5 containing 20 to 50 mol%,
An antibacterial artificial marble comprising an antibacterial agent and a thermosetting resin containing glass having an alkali metal oxide content of 0 to 1 mol% as an active ingredient.
【0008】[0008]
【発明の実施の形態】以下、本発明について詳細に説明
する。 ○抗菌剤 本発明における抗菌剤(以下、ガラス質抗菌剤と略称す
る)は、ZnOを50〜80モル%と、B2O3および/
またはP2O5を20〜50モル%含有し、アルカリ金属
酸化物の含有割合が0〜1モル%であるガラスを有効成
分とするものである。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail. ○ antimicrobial antimicrobials in the present invention (hereinafter, abbreviated as vitreous antimicrobial agent), 50 to 80 mol% of ZnO, B 2 O 3 and /
Or P 2 O 5 containing 20 to 50 mol%, the content of alkali metal oxides is as an active ingredient a glass 0-1 mol%.
【0009】好ましいZnOの含有割合は、55〜75
モル%であり、より好ましくは、60〜70モル%であ
る。ZnOを80モル%より多く配合すると、安定して
ガラス化させにくいという問題があり、50モル%未満
では本発明のガラスの抗菌性が不十分となる。The preferred ZnO content is 55-75.
Mol%, more preferably 60 to 70 mol%. If ZnO is added in an amount of more than 80 mol%, there is a problem that it is difficult to vitrify stably, and if it is less than 50 mol%, the antibacterial properties of the glass of the present invention become insufficient.
【0010】好ましいB2O3および/またはP2O5の含
有割合は、25〜45モル%であり、より好ましくは3
0〜40モル%である。B2O3および/またはP2O5を
50モル%より多く配合すると、本発明のガラスの水溶
解性が大きくなってしまい、本発明のガラスが有する優
れた抗菌性、耐変色性が損なわれるという問題があり、
20モル%未満では安定してガラス化させにくいという
問題がある。B2O3とP2O5の配合は両方又はどちらか
一方のみであっても良い。A preferable content ratio of B 2 O 3 and / or P 2 O 5 is 25 to 45 mol%, more preferably 3 to 45 mol%.
0 to 40 mol%. If B 2 O 3 and / or P 2 O 5 is added in an amount of more than 50 mol%, the water solubility of the glass of the present invention increases, and the excellent antibacterial properties and discoloration resistance of the glass of the present invention are impaired. There is a problem that
If it is less than 20 mol%, there is a problem that it is difficult to stabilize the glass. The blend of B 2 O 3 and P 2 O 5 may be both or only one of them.
【0011】本発明におけるガラス質抗菌剤において、
アルカリ金属酸化物の含有割合は0〜1モル%であり、
このことは本発明の人工大理石において優れた抗菌性、
耐変色性を発揮させる上で極めて重要である。即ち、ア
ルカリ金属酸化物の含有割合が1モル%より大きいと、
本発明におけるガラス質抗菌剤の水溶解性が極めて大き
くなってしまい、本発明の人工大理石における持続性の
ある抗菌性、耐変色性が損なわれてしまう。In the vitreous antibacterial agent of the present invention,
The content ratio of the alkali metal oxide is 0 to 1 mol%,
This means that the artificial marble of the present invention has excellent antibacterial properties,
It is extremely important for exhibiting discoloration resistance. That is, when the content of the alkali metal oxide is more than 1 mol%,
The water solubility of the vitreous antibacterial agent of the present invention becomes extremely large, and the sustained antibacterial property and discoloration resistance of the artificial marble of the present invention are impaired.
【0012】本発明における必須のガラス形成成分は、
B2O3又はP2O5であるが、所望によりその他のガラス
形成成分を追加することができる。その他のガラス形成
成分の好ましい例として、SiO2、Al2O3、Ti
O2、ZrO2等がある。その他のガラス形成成分の好ま
しい含有割合は、20モル%以下であり、より好ましく
は15モル%以下である。The essential glass-forming components in the present invention are:
B 2 O 3 or is a P 2 O 5, it is possible to add other glass forming ingredients as desired. Preferred examples of other glass-forming components include SiO 2 , Al 2 O 3 , and Ti.
O 2 , ZrO 2 and the like. The preferable content ratio of other glass-forming components is 20 mol% or less, more preferably 15 mol% or less.
【0013】又、所望により、MgO、CaO及びCa
F2等を適宜含有させることができる。これらの所謂
「修飾成分」は、ガラスの溶融や成形性を容易にするの
に有効であるが、多量に含有させると、ガラスの耐水性
が低下する恐れがあるので、多くとも3モル%以下とす
るのが好ましく、より好ましくは1モル%以下である。If desired, MgO, CaO and Ca
F 2 and the like can be appropriately contained. These so-called “modifying components” are effective in facilitating melting and moldability of the glass, but when contained in a large amount, the water resistance of the glass may be reduced, so that at most 3 mol% or less. And more preferably 1 mol% or less.
【0014】本発明におけるガラス質抗菌剤を製造する
方法に制限はなく、既知の製造方法を採用できる。一般
には、ガラスの原料調合物を溶融釜で1000〜200
0℃で溶解した後、溶解物を急冷して、ガラスを調製
後、得られた塊状ガラスを粉砕することにより粉末状の
ガラスを容易に得ることができる。The method for producing the vitreous antibacterial agent in the present invention is not limited, and a known production method can be employed. Generally, the raw material mixture of glass is 1000-200 in a melting pot.
After melting at 0 ° C., the melt is quenched to prepare a glass, and then the obtained lump glass is ground to easily obtain a powdery glass.
【0015】本発明におけるガラス質抗菌剤の有効成分
であるガラスは、従来と比較して格段に優れた抗菌性を
発揮させるために、酸化亜鉛(融点:約2000℃)の濃度
が従来の抗菌剤用ガラスに比較して高いので、ガラス化
が難しいと考えられるかもしれないが、これは思い過ご
しである。酸化亜鉛自体はガラスの網目を形成する能力
を有しているので、適当な溶融温度で溶解し、溶融物の
冷却特性に合った急冷手段を用いれば、本発明における
任意の組成を有するガラスを容易に得ることができる。The glass, which is an active ingredient of the vitreous antibacterial agent of the present invention, has a zinc oxide (melting point: about 2000 ° C.) concentration of the conventional antibacterial agent in order to exhibit a much superior antibacterial property as compared with the conventional one. It may be considered difficult to vitrify because it is expensive compared to prescription glass, but this is overlooked. Zinc oxide itself has the ability to form a network of glass, so if it is melted at an appropriate melting temperature and quenching means suitable for the cooling characteristics of the melt is used, glass having any composition in the present invention can be obtained. Can be easily obtained.
【0016】急冷効果を高めるには、溶解物と冷却体と
の接触面積を大きくすることが有効であり、例えば水等
の冷媒で冷却された2個の回転する金属ローラー間にガ
ラスの溶解物を高速で通すことにより、極めて大きな冷
却効果が得られ、この冷却方法を用いれば、ガラス化は
極めて容易である。又、この方法により冷却すると、ロ
ーラー間から出たガラスは薄い板状に成形されているの
で、粉末状に粉砕することも極めて容易に行うことがで
きる。In order to enhance the quenching effect, it is effective to increase the contact area between the molten material and the cooling body. For example, the molten material of glass is sandwiched between two rotating metal rollers cooled by a coolant such as water. Is passed through at a high speed to obtain an extremely large cooling effect. By using this cooling method, vitrification is extremely easy. Further, when cooled by this method, since the glass that has come out between the rollers is formed into a thin plate, it can be very easily crushed into a powder.
【0017】○4価金属リン酸塩系抗菌剤 本発明におけるガラス質抗菌剤は、4価金属リン酸塩系
抗菌剤を併用すると、その抗菌性を一層高めることがで
きる。これはガラス中の亜鉛イオンと4価金属リン酸塩
系抗菌剤中の抗菌性金属イオンの2種の異なる抗菌成分
による相乗効果が得られるためである。(4) Antibacterial agent of tetravalent metal phosphate When the vitreous antibacterial agent of the present invention is used in combination with the antibacterial agent of tetravalent metal phosphate, its antibacterial property can be further enhanced. This is because a synergistic effect is obtained by two different antibacterial components of zinc ions in glass and antibacterial metal ions in the tetravalent metal phosphate antibacterial agent.
【0018】また、本発明におけるガラス質抗菌剤は、
その耐変色防止効果が極めて優れているので、4価金属
リン酸塩系抗菌剤を併用することで樹脂製品の着色、変
色が起こることはない。本発明における4価金属リン酸
塩系抗菌剤は、下記一般式〔1〕で示される。 M1aAbM2c(PO4)d・nH2O 〔1〕 (M1は銀、銅、亜鉛、錫、水銀、鉛、鉄、コバルト、
ニッケル、マンガン、砒素、アンチモン、ビスマス、バ
リウム、カドミウム及びクロムから選ばれる少なくとも
1種のl価(lは正の整数)の金属イオンであり、Aは
アルカリ金属イオン、アルカリ土類金属イオン、アンモ
ニウムイオン及び水素イオンから選ばれる少なくとも1
種のm価(mは正の整数)のイオンであり、M2は4価
金属イオンであり、nは0≦n≦6を満たす数であり、
a及びbはいずれもla+mb=1又はla+mb=2
を満たす正数であり、c及びdはla+mb=1の時、
c=2、d=3であり、la+mb=2の時c=1,d
=2である。)Further, the vitreous antibacterial agent in the present invention comprises:
Since the anti-discoloration effect is extremely excellent, the coloring and discoloration of the resin product will not occur when a tetravalent metal phosphate antibacterial agent is used in combination. The tetravalent metal phosphate antibacterial agent in the present invention is represented by the following general formula [1]. M 1 aAb M 2 c (PO 4 ) d · nH 2 O [1] (M 1 is silver, copper, zinc, tin, mercury, lead, iron, cobalt,
At least one l-valent (l is a positive integer) metal ion selected from nickel, manganese, arsenic, antimony, bismuth, barium, cadmium, and chromium, and A is an alkali metal ion, an alkaline earth metal ion, or ammonium At least one selected from ions and hydrogen ions
A species of m-valent (m is a positive integer) ion, M 2 is a tetravalent metal ion, n is a number satisfying 0 ≦ n ≦ 6,
a and b are both la + mb = 1 or la + mb = 2
Where c and d are la + mb = 1,
c = 2, d = 3, and when la + mb = 2, c = 1, d
= 2. )
【0019】上記一般式〔1〕で示される化合物は、層
状構造又は空間群R3 Cに属する3次元編目状構造を有
する結晶性化合物又はアモルファスである。本発明にお
ける4価金属リン酸塩系抗菌剤は、物性変化が少ないこ
とから3次元網目状構造を有する結晶性化合物が好まし
い。上記一般式〔1〕におけるM1は、いずれも防か
び、抗菌性及び防藻性を示す金属として知られたもので
あり、これらの中で銀は、安全性の他、防かび、抗菌性
及び防藻性を高めることができる金属として特に有効で
ある。The compound represented by the general formula [1] is a crystalline compound or an amorphous compound having a layered structure or a three-dimensional knitted structure belonging to the space group R3C. As the tetravalent metal phosphate antibacterial agent in the present invention, a crystalline compound having a three-dimensional network structure is preferable because there is little change in physical properties. M 1 in the above general formula [1] is known as a metal having antifungal, antibacterial and antialgal properties, and among these, silver is not only safe but also antifungal and antibacterial. It is particularly effective as a metal capable of enhancing algal resistance.
【0020】上記一般式〔1〕におけるAは、アルカリ
金属イオン、アルカリ土類金属イオン、アンモニウムイ
オン又は水素イオンから選ばれる少なくとも1種のイオ
ンであり、好ましい具体例には、リチウム、ナトリウム
及びカリウム等のアルカリ金属イオン、マグネシウム又
はカルシウム等のアルカリ土類金属イオン又は水素イオ
ンがあり、これらの中では、化合物の安定性及び安価に
入手できる点からカリウム、ナトリウム及び水素イオン
が好ましいイオンである。A in the general formula [1] is at least one ion selected from the group consisting of an alkali metal ion, an alkaline earth metal ion, an ammonium ion and a hydrogen ion. Preferred examples thereof include lithium, sodium and potassium. And alkaline earth metal ions such as magnesium and calcium or hydrogen ions. Among these, potassium, sodium and hydrogen ions are preferred ions in view of the stability of the compound and availability at low cost.
【0021】上記一般式〔1〕におけるM2は、4価金
属イオンであり、好ましい具体例には、ジルコニウム、
チタン又は錫があり、化合物の安全性を考慮すると、ジ
ルコニウム及びチタンは、特に好ましい4価金属イオン
である。M 2 in the general formula [1] is a tetravalent metal ion, and preferred specific examples thereof include zirconium,
There are titanium and tin, and considering the safety of the compound, zirconium and titanium are particularly preferred tetravalent metal ions.
【0022】防かび、抗菌性及び防藻性を発揮させるに
は、一般式〔1〕におけるaの値は大きい方がよいが、
aの値が0. 001以上であれば、充分に防かび、抗菌
性及び防藻性を発揮させることができる。しかし、aの
値が0. 001未満であると、防かび、抗菌性及び防藻
性を長時間発揮させることが困難となる恐れがあるの
で、aの値を0. 01以上の値とすることが好ましい。
また、少量の添加で効果を得るためにはaの値は0.1
以上とすることがより好ましい。In order to exhibit the fungicidal, antibacterial and algicidal properties, the larger the value of a in the general formula [1], the better.
When the value of a is 0.001 or more, it is possible to sufficiently exhibit fungicide, antibacterial properties and antialgal properties. However, if the value of a is less than 0.001, it may be difficult to exhibit the fungicide, antibacterial properties and anti-algal properties for a long time, so the value of a is set to 0.01 or more. Is preferred.
Further, in order to obtain an effect by adding a small amount, the value of a is 0.1
It is more preferable to make the above.
【0023】上記一般式〔1〕の抗菌剤の好ましい具体
例として、以下のものがある。 Ag0.001Li1.999Zr(PO4)2 Ag0.01Na1.99Zr(PO4)2 Ag0.01K1.99Sn(PO4)2・1.2H2O Ag0.1 (NH4)1.9 Ti(PO4)2・4H2O 及び化合物1モル当たりの銀イオンの電荷量と同じ電荷
量になるようにしながら、上記各式におけるAgをZ
n、Mn、Ni、Pb、Hg、Sn、又はCuと置換し
た化合物である。又、以下の抗菌剤も好ましいものであ
る。 Ag0.005 Li0.995 Zr2(PO4)3 Ag0.01(NH4)0.99Zr2(PO4)3 Ag0.05Na0.95Zr2(PO4)3 Ag0.2 K0.8Ti2(PO4)3 Ag0.1 H0.9Zr2(PO4)3 Ag0.40H0.15Na0.45Zr2 (PO4)3 Ag0.60H0.10Na0.30Zr2 (PO4)3 及び化合物1モル当たりの銀イオンの電荷量と同じ電荷
量になるようにしながら、上記各式におけるAgをZ
n、Mn、Ni、Pb、Hg、Sn、又はCuと置換し
た化合物等である。Preferred specific examples of the antibacterial agent represented by the general formula [1] are as follows. Ag 0.001 Li 1.999 Zr (PO 4 ) 2 Ag 0.01 Na 1.99 Zr (PO 4 ) 2 Ag 0.01 K 1.99 Sn (PO 4 ) 2 1.2 H 2 O Ag 0.1 (NH 4 ) 1.9 Ti (PO 4 ) 2. Ag in each of the above formulas was changed to Z while maintaining the same charge as the charge of silver ions per mole of 4H 2 O and compound.
It is a compound substituted with n, Mn, Ni, Pb, Hg, Sn, or Cu. The following antibacterial agents are also preferable. Ag 0.005 Li 0.995 Zr 2 (PO 4 ) 3 Ag 0.01 (NH 4 ) 0.99 Zr 2 (PO 4 ) 3 Ag 0.05 Na 0.95 Zr 2 (PO 4 ) 3 Ag 0.2 K 0.8 Ti 2 (PO 4 ) 3 Ag 0.1 H 0.9 Zr 2 (PO 4 ) 3 Ag 0.40 H 0.15 Na 0.45 Zr 2 (PO 4 ) 3 Ag 0.60 H 0.10 Na 0.30 Zr 2 (PO 4 ) 3 and the same charge amount as silver ion per mole of compound In each of the above equations, Ag is changed to Z
Compounds substituted with n, Mn, Ni, Pb, Hg, Sn, or Cu.
【0024】本発明における4価金属リン酸塩系抗菌剤
は、抗菌性金属イオンをリン酸塩系化合物に担持させた
ものであり、リン酸塩系化合物を合成する方法には、焼
成法、湿式法及び水熱法等があり、公知の製造方法によ
り容易に得ることができる。[0024] The tetravalent metal phosphate antibacterial agent of the present invention is obtained by supporting an antibacterial metal ion on a phosphate compound. There are a wet method, a hydrothermal method and the like, which can be easily obtained by a known production method.
【0025】4価金属リン酸塩系化合物に抗菌性金属イ
オンを担持させる方法には特に制限はない。しかし、イ
オン交換反応により担持させる方法が一般的である。The method for supporting the antibacterial metal ion on the tetravalent metal phosphate compound is not particularly limited. However, a method of supporting by an ion exchange reaction is generally used.
【0026】○ガラス質抗菌剤と4価金属リン酸塩系抗
菌剤の配合割合 本発明における4価金属リン酸塩系抗菌剤の好ましい配
合割合は、本発明におけるガラス質抗菌剤との合計重量
100重量部(以下、部と略す)当たり0〜70部であ
り、より好ましくは0〜50部である。70部より多く
しても、ガラス質抗菌剤との併用効果の大きな向上が望
めず、一方樹脂に添加した際に、4価金属リン酸塩系抗
菌剤による変色が起こる恐れがある。The blending ratio of the glassy antibacterial agent and the tetravalent metal phosphate antibacterial agent The preferred blending ratio of the tetravalent metal phosphate antibacterial agent in the present invention is the total weight of the glassy antibacterial agent and the present invention. The amount is from 0 to 70 parts, more preferably from 0 to 50 parts, per 100 parts by weight (hereinafter abbreviated as "part"). Even if the amount is more than 70 parts, it is not possible to expect a great improvement in the combined effect with the vitreous antibacterial agent. On the other hand, when added to the resin, discoloration due to the tetravalent metal phosphate antibacterial agent may occur.
【0027】また、本発明における抗菌性人工大理石に
は、ガラス質抗菌剤又はこれに4価金属リン酸塩系抗菌
剤を配合した抗菌剤組成物以外に、その他の物性を改善
するために、必要に応じて種々の他の添加剤を混合する
こともできる。具体例としては、酸化防止剤、耐光安定
剤、帯電防止剤、耐衝撃強化剤などがある。In addition, the antibacterial artificial marble of the present invention contains, in addition to a vitreous antibacterial agent or an antibacterial agent composition containing a tetravalent metal phosphate-based antibacterial agent added thereto, to improve other physical properties. Various other additives can be mixed as needed. Specific examples include antioxidants, light stabilizers, antistatic agents, and impact modifiers.
【0028】○抗菌剤組成物の調製方法 本発明におけるガラス質抗菌剤と4価金属リン酸塩系抗
菌剤の混合方法は特に制限はない。例えば、ヘンシェル
ミキサ−を用いての混合が挙げられ、混合条件は混合量
により適宜、回転数(800〜3000rpm)と混合
時間(数分〜数十分)のみで調整を行えばよく、常温常
圧で行うことが可能である。Method for Preparing Antibacterial Agent Composition The method for mixing the vitreous antibacterial agent and the tetravalent metal phosphate antibacterial agent in the present invention is not particularly limited. For example, mixing using a Henschel mixer may be mentioned, and the mixing conditions may be appropriately adjusted only by the rotation speed (800 to 3000 rpm) and the mixing time (several minutes to several tens of minutes) depending on the mixing amount. It can be done with pressure.
【0029】○熱硬化性樹脂 本発明の抗菌性人工大理石は、人工大理石の全体に抗菌
剤を含有させたものと人工大理石の表面を構成するゲル
コート層に抗菌剤を含有させたものがある。ゲルコート
層を有する場合と有しない場合の何れの場合も人工大理
石基材及びゲルコート層は熱硬化性樹脂からなる。Thermosetting Resin The antibacterial artificial marble of the present invention includes those in which an antibacterial agent is contained in the entire artificial marble and those in which a gelcoat layer constituting the surface of the artificial marble contains an antibacterial agent. In both cases with and without the gel coat layer, the artificial marble substrate and the gel coat layer are made of a thermosetting resin.
【0030】本発明に用いる熱硬化性樹脂としては、硬
化して人工大理石基材又はゲルコート層を形成できる樹
脂であれば特に制限はなく、例えば、イソフタル酸系不
飽和ポリエステル、テレフタル酸系不飽和ポリエステ
ル、エポキシ(メタ)アクリレート、メラミンアクリレ
ート、メラミン(メタ)アクリレート、(メタ)アクリ
レート、メチル(メタ)アクリレートなどのポリマー、
オリゴマーあるいはこれらの重合体を形成する重合性単
量体の少なくとも1種を主成分とするもの等がある。The thermosetting resin used in the present invention is not particularly limited as long as it is a resin capable of being cured to form an artificial marble base material or a gel coat layer. Examples thereof include an isophthalic unsaturated polyester and a terephthalic unsaturated polyester. Polymers such as polyester, epoxy (meth) acrylate, melamine acrylate, melamine (meth) acrylate, (meth) acrylate, methyl (meth) acrylate,
There are oligomers and those containing at least one polymerizable monomer forming these polymers as a main component.
【0031】又、必要に応じ、架橋剤、硬化剤、硬化促
進剤、着色剤等を添加することができる。架橋剤とし
て、エチレングリコールジ(メタ)アクリレート、トリ
エチレングリコールジ(メタ)アクリレート、トリエチ
レングリコールジ(メタ)アクリレート等が挙げられ
る。硬化剤として、ターシャリーブチルパーオキシマレ
イン酸、過酸化ベンゾイル、メチルエトルケトンパーオ
キサイド等が挙げられる。硬化促進剤として、ナフテン
酸コバルト等が挙げられる。If necessary, a crosslinking agent, a curing agent, a curing accelerator, a coloring agent, and the like can be added. Examples of the crosslinking agent include ethylene glycol di (meth) acrylate, triethylene glycol di (meth) acrylate, and triethylene glycol di (meth) acrylate. Examples of the curing agent include tertiary butyl peroxymaleic acid, benzoyl peroxide, and methyl etoketone peroxide. Examples of the curing accelerator include cobalt naphthenate.
【0032】ガラス質抗菌剤又はこれと4価金属リン酸
塩系抗菌剤を配合した抗菌剤組成物を人工大理石用組成
物に配合する方法は公知の方法をどれも採用できる。例
えば、人工大理石用組成物にガラス質抗菌剤又は抗菌剤
組成物を所定量添加し、ニーダー、ミキサー、ロールミ
ル、押し出し機等で混練、混合すればよい。ガラス質抗
菌剤又は抗菌剤組成物の人工大理石又はゲルコート層に
おける好ましい配合割合は、人工大理石又はゲルコート
層100部当たり0.05〜10部であり、より好まし
くは0.5〜5部である。0.05部より少ないと抗菌性
人工大理石の抗菌性が不充分となる恐れがあり、一方1
0部より多く配合しても抗菌効果の向上が殆どない。Any known method can be used to mix the glassy antibacterial agent or the antibacterial agent composition containing the same with the tetravalent metal phosphate antibacterial agent in the composition for artificial marble. For example, a predetermined amount of a vitreous antibacterial agent or an antibacterial agent composition may be added to the composition for artificial marble, and kneaded and mixed with a kneader, mixer, roll mill, extruder, or the like. A preferred compounding ratio of the vitreous antibacterial agent or the antibacterial agent composition in the artificial marble or gel coat layer is 0.05 to 10 parts, more preferably 0.5 to 5 parts, per 100 parts of the artificial marble or gel coat layer. If the amount is less than 0.05 part, the antibacterial property of the artificial marble may be insufficient.
Even if it is more than 0 parts, there is almost no improvement in the antibacterial effect.
【0033】○抗菌性人工大理石の作製方法 抗菌性人工大理石は、次のようにして作製される。熱硬
化性樹脂、硬化触媒、ガラス質抗菌剤またはこれと4価
金属リン酸塩系抗菌剤を配合した抗菌剤組成物を混合す
る。必要に応じ、ガラス繊維や水酸化アルミニウム等の
無機質充填材、架橋剤、硬化促進剤、顔料等を添加、混
合すればよい。この混合物を型に注入し、室温または加
熱により硬化させることにより人工大理石が得られる。
注入成型以外にも、射出成型、プレス成型等、他の成型
方法を用いることも可能であるが、注入成型が最も好ま
しい。Method for Producing Antibacterial Artificial Marble Antibacterial artificial marble is produced as follows. A thermosetting resin, a curing catalyst, a glassy antibacterial agent, or an antibacterial agent composition containing the same and a tetravalent metal phosphate-based antibacterial agent are mixed. If necessary, an inorganic filler such as glass fiber or aluminum hydroxide, a crosslinking agent, a curing accelerator, a pigment and the like may be added and mixed. The mixture is poured into a mold and cured at room temperature or by heating to obtain an artificial marble.
In addition to injection molding, other molding methods such as injection molding and press molding can be used, but injection molding is most preferable.
【0034】又、ゲルコート層を基材樹脂の表面に有す
る人工大理石の場合は、一般に次のようにして作製され
る。成型用の型に、ゲルコート層作製用塗料組成物をス
プレーアップ法等により塗装、硬化させる。次に基材樹
脂用組成物を型に注入し、硬化させる。ゲルコート層と
基材樹脂の積層品を脱型することにより、人工大理石が
得られる。In the case of artificial marble having a gel coat layer on the surface of the base resin, it is generally prepared as follows. A coating composition for preparing a gel coat layer is applied to a molding die and cured by a spray-up method or the like. Next, the composition for base resin is poured into a mold and cured. By removing the laminate of the gel coat layer and the base resin, an artificial marble can be obtained.
【0035】[0035]
【作用】本発明におけるガラス質抗菌剤が優れた抗菌
性、耐変色性を有する機構について以下のように推定さ
れる。即ち、本発明におけるガラス質抗菌剤は高濃度の
ZnOを含有し、且つアルカリ金属の含有割合が極めて
低濃度であることから、水溶解性が極めて小さく、先ず
耐水性に優れる。ガラス質抗菌剤を構成するガラスの表
面層はZnの溶出が少ないので、ガラス表面層には常に
高濃度のZnが存在し、Znによる抗菌性を長期間持続
させることができる。また、ガラス質抗菌剤の水溶解性
が小さいので変色要因となるZnイオンやアルカリ金属
イオンの溶出が少なく、耐変色性が優れる。上記のガラ
ス質抗菌剤と本特許に使用される4価金属リン酸塩系抗
菌剤を併用すると、各々が単独の場合より抗菌性が向上
するのは、複数の抗菌剤を共存させるとそれぞれの抗菌
剤の相乗効果が発揮されるものと推定される。The mechanism by which the vitreous antibacterial agent of the present invention has excellent antibacterial properties and discoloration resistance is presumed as follows. That is, since the vitreous antibacterial agent of the present invention contains a high concentration of ZnO and has a very low alkali metal content, it has extremely low water solubility and, first, is excellent in water resistance. Since the surface layer of the glass constituting the vitreous antibacterial agent has a low elution of Zn, the glass surface layer always has a high concentration of Zn, and the antibacterial property of Zn can be maintained for a long time. In addition, since the water solubility of the vitreous antibacterial agent is small, elution of Zn ions and alkali metal ions, which cause discoloration, is small, and the discoloration resistance is excellent. When the above glassy antibacterial agent and the tetravalent metal phosphate-based antibacterial agent used in this patent are used in combination, the antibacterial property is improved as compared with the case where each is used alone. It is presumed that a synergistic effect of the antibacterial agent is exhibited.
【0036】[0036]
【実施例】以下、本発明を実施例によりさらに具体的に
説明する。 合成例1(4価金属リン酸塩系抗菌剤) 硫酸ジルコニウムの水溶液及びリン酸の水溶液をジルコ
ニウムとリンの比が2:3になるように混合することに
より沈澱物を生じさせ、水酸化ナトリウムの水溶液を用
いてpHを2に調整したのち、水熱状態下で130℃、
12時間加熱することにより結晶性リン酸ジルコニウム
〔NaZr2(PO4)3〕を得た。上記で得たリン酸塩
系化合物をよく水洗後、硝酸銀及び1Nの硝酸水溶液に
添加し、60℃で4時間撹拌した後、充分に水洗、乾燥
した。これを焼成炉にて750℃で4時間焼成した後、
粉砕することにより銀系無機抗菌剤Ag0.50Na0.23H
0.27Zr2(PO4)3を得た。得られた銀系無機抗菌剤
は平均粒径が0.92μである白色粉末である。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. Synthesis Example 1 (tetravalent metal phosphate antibacterial agent) A precipitate was formed by mixing an aqueous solution of zirconium sulfate and an aqueous solution of phosphoric acid so that the ratio of zirconium to phosphorus was 2: 3, and sodium hydroxide was used. After adjusting the pH to 2 using an aqueous solution of 130 ° C. under hydrothermal conditions,
By heating for 12 hours, crystalline zirconium phosphate [NaZr 2 (PO 4 ) 3 ] was obtained. The phosphate compound obtained above was thoroughly washed with water, added to silver nitrate and a 1N aqueous solution of nitric acid, stirred at 60 ° C. for 4 hours, thoroughly washed with water, and dried. After firing this at 750 ° C. for 4 hours in a firing furnace,
Silver based inorganic antibacterial agent Ag 0.50 Na 0 by grinding. 23 H
0. To give the 27 Zr 2 (PO 4) 3 . The obtained silver-based inorganic antibacterial agent is a white powder having an average particle size of 0.92 μm.
【0037】合成例2(ゼオライト系抗菌剤の調製) 合成例1で合成した結晶性リン酸ジルコニウムに代え
て、市販のゼオライト4Aを用いた以外は参考例1と同
様にして、銀の含有割合が4重量%である抗菌性ゼオラ
イトを得た。Synthesis Example 2 (Preparation of zeolite-based antibacterial agent) The content of silver was changed in the same manner as in Reference Example 1 except that commercially available zeolite 4A was used instead of the crystalline zirconium phosphate synthesized in Synthesis Example 1. Was 4% by weight.
【0038】参考例1(ガラス質抗菌剤の調製) 表1において試料No.1〜No.3で示した組成の原料
調合物を1000〜1400℃で溶解してガラスを作製
後、得られたガラスをボ−ルミルにて湿式粉砕して平均
粒径約10μmのガラス質抗菌剤を得た。Reference Example 1 (Preparation of vitreous antibacterial agent) A raw material mixture having the composition shown in Samples No. 1 to No. 3 in Table 1 was melted at 1000 to 1400 ° C. to produce a glass. The glass was wet-pulverized with a ball mill to obtain a glassy antibacterial agent having an average particle size of about 10 μm.
【0039】比較参考例1(ガラス質抗菌剤の調製) 表1において試料No.4〜No.6で示した組成の原料
調合物を用いた以外は参考例1と同様にして平均粒径約
10μmのガラス質抗菌剤を得た。Comparative Reference Example 1 (Preparation of vitreous antibacterial agent) The average particle diameter was approximately the same as in Reference Example 1 except that the raw material preparations having the compositions shown in Samples Nos. 4 to 6 in Table 1 were used. A 10 μm glassy antimicrobial agent was obtained.
【0040】参考例2(抗菌剤組成物の調製) 合成例1にて調製した4価金属リン酸塩系抗菌剤とガラ
ス質抗菌剤試料No.1または3を、表2に示した割合
で配合して抗菌剤組成物(試料No.7〜試料No.1
0)を得た。Reference Example 2 (Preparation of Antibacterial Agent Composition) The tetravalent metal phosphate-based antibacterial agent prepared in Synthesis Example 1 and the vitreous antibacterial agent sample No. 1 or 3 were prepared at the ratios shown in Table 2. The antibacterial agent composition (Sample No. 7 to Sample No. 1)
0) was obtained.
【0041】[0041]
【表1】 [Table 1]
【0042】[0042]
【表2】 [Table 2]
【0043】実施例1 ポリメチルメタアクリレート/メチルメタアクリレート
100部に対して、水酸化アルミニウム150部を添加
し、さらに硬化剤、硬化促進剤を加えた人工大理石樹脂
組成物100部に対して、参考例1及び参考例2にて調
製した各種ガラス質抗菌剤(試料No.1〜No.3)又
は抗菌剤組成物(試料No.7〜10)を1.0部添加、
混合した。この組成物を型内に注入、室温で硬化、脱型
させることにより抗菌性人工大理石を得た(試作No.1
〜No.3、試作No.7〜10。但し、試作No.Kの人工
大理石は試料No.Kのガラス質抗菌剤、抗菌剤組成物又
は抗菌剤を用いて作製したものである(Kは正の整
数)。以下、比較例1において同様に表示した)。Example 1 150 parts of aluminum hydroxide was added to 100 parts of polymethyl methacrylate / methyl methacrylate, and a curing agent and a curing accelerator were added to 100 parts of the artificial marble resin composition. 1.0 part of various glassy antibacterial agents (Sample Nos. 1 to 3) or antibacterial agent compositions (Samples Nos. 7 to 10) prepared in Reference Examples 1 and 2 were added,
Mixed. This composition was poured into a mold, cured at room temperature, and demolded to obtain an antibacterial artificial marble (prototype No. 1).
No. 3 and prototype Nos. 7 to 10. However, the artificial marble of prototype No. K was prepared using the glassy antibacterial agent, antibacterial agent composition or antibacterial agent of sample No. K (K is a positive integer). Hereinafter, it is similarly indicated in Comparative Example 1).
【0044】比較例1 実施例1におけるガラス質抗菌剤又は抗菌剤組成物に代
えて、参考例2で調製した試料No.4〜No.6のガラ
ス質抗菌剤を用いた以外は実施例1と同様にして抗菌性
人工大理石を得た(試作No.4〜No.6)。Comparative Example 1 Example 1 was repeated except that the vitreous antibacterial agents of Samples Nos. 4 to 6 prepared in Reference Example 2 were used instead of the vitreous antibacterial agent or the antibacterial agent composition in Example 1. Antibacterial artificial marble was obtained in the same manner as described above (prototypes No. 4 to No. 6).
【0045】比較例2 実施例1におけるガラス質抗菌剤又は抗菌剤組成物に代
えて、合成例1で調製した抗菌剤を用いた以外は実施例
1と同様にして抗菌性人工大理石を得た(試作No.1
1)。Comparative Example 2 An antibacterial artificial marble was obtained in the same manner as in Example 1 except that the antibacterial agent prepared in Synthesis Example 1 was used instead of the vitreous antibacterial agent or the antibacterial agent composition in Example 1. (Prototype No.1
1).
【0046】比較例3 実施例1におけるガラス質抗菌剤又は抗菌剤組成物に代
えて、合成例2で調製した抗菌剤を用いた以外は実施例
1と同様にして抗菌性人工大理石を得た(試作No.1
2)。Comparative Example 3 An antibacterial artificial marble was obtained in the same manner as in Example 1, except that the antibacterial agent prepared in Synthesis Example 2 was used instead of the vitreous antibacterial agent or the antibacterial agent composition in Example 1. (Prototype No.1
2).
【0047】比較例4 抗菌剤を添加しなかったこと以外は実施例1と同様にし
て人工大理石を得た(試作No.13)。Comparative Example 4 An artificial marble was obtained in the same manner as in Example 1 except that no antibacterial agent was added (prototype No. 13).
【0048】評価試験1 実施例1及び比較例1〜4にて作製した抗菌性人工大理
石の色彩を目視で確認することで変色性評価とした。ま
た、作製した成型体の抗菌力を、以下の方法により評価
した。被検菌には大腸菌を用い、抗菌性人工大理石を5
cm×5cm×2mmのプレートに切断し、プレート表
面1枚当りの菌数が105〜106個となるように菌液
0.5mlを表面に滴下した。その上から4.5cm×
4.5cmのポリエチレン製フィルムを被せ、菌液を表
面に一様に接触させ、温度35℃、湿度95RH%で2
4時間保存した。保存開始直後(理論添加菌数)及び2
4時間保存した後に、菌数測定用培地(SCDLP液体
培地)でプレート上の生残菌を洗い出し、この洗液につ
いて、普通寒天培地を用いる混釈平板培養法(37℃2
日間)により生菌数を測定して、プレートの5cm×5
cm当りの生菌数に換算した。なお、初発菌数は1.4
×105であり、サンプルを用いずに同様の操作を行っ
た対照の菌数は9.5×106であった。さらに、プレ
ートを、80℃の温水に500時間浸漬させた後の色
彩、及び抗菌力を評価し、その結果を表3に合わせて示
した。Evaluation Test 1 The color of the antibacterial artificial marble prepared in Example 1 and Comparative Examples 1 to 4 was visually checked for discoloration evaluation. Further, the antibacterial activity of the produced molded body was evaluated by the following method. Escherichia coli is used as the test bacterium, and antibacterial artificial marble
The plate was cut into a plate of cm × 5 cm × 2 mm, and 0.5 ml of a bacterial solution was dropped on the surface so that the number of bacteria per one plate surface was 10 5 to 10 6 . 4.5cm from above
A 4.5 cm polyethylene film is placed on the surface, and the bacterial solution is uniformly contacted with the surface.
Stored for 4 hours. Immediately after the start of storage (the number of theoretically added bacteria) and 2
After storage for 4 hours, the surviving bacteria on the plate are washed out with a culture medium for cell count (SCDLP liquid medium), and the washed liquid is subjected to a pour plate culture method (37 ° C. 2
Days), the number of viable bacteria was measured, and 5 cm × 5
It was converted to the number of viable bacteria per cm. The initial number of bacteria was 1.4.
× 10 5 , and the number of bacteria of a control which was subjected to the same operation without using the sample was 9.5 × 10 6 . Further, the color and the antibacterial activity after immersing the plate in hot water of 80 ° C. for 500 hours were evaluated, and the results are shown in Table 3.
【0049】[0049]
【表3】 [Table 3]
【0050】本発明におけるガラス質抗菌剤または抗菌
剤組成物を配合した抗菌性人工大理石(試作No.1〜
3、及び7〜10)は抗菌性、耐変色性、耐温水性とも
優れた性能を有していることが確認された。一方、 Z
nOの含有割合は大きいが、アルカリ金属酸化物の含有
割合が1モル%より大きいガラス質抗菌剤を配合したプ
レート(試作No.4)は、耐変色性に劣り、ZnOの配
合モル比の小さい抗菌剤用ガラスを配合したプレート
(試作No.5)は抗菌性に劣る結果となった。また、ガ
ラス中に亜鉛と共に銀を含有させたプレート(試作No.
6)は耐変色性に劣る結果となった。Antibacterial artificial marble containing the vitreous antibacterial agent or antibacterial agent composition of the present invention (prototype Nos. 1 to 3)
Nos. 3, and 7 to 10) were confirmed to have excellent antibacterial properties, discoloration resistance, and warm water resistance. On the other hand, Z
Although the content ratio of nO is large, the plate (prototype No. 4) containing the vitreous antibacterial agent in which the content ratio of alkali metal oxide is larger than 1 mol% is inferior in discoloration resistance and the mixing molar ratio of ZnO is small. The plate containing the antimicrobial glass (prototype No. 5) was inferior in antimicrobial properties. In addition, a plate containing silver together with zinc in glass (prototype No.
6) resulted in poor discoloration resistance.
【0051】実施例2 イソフタル酸系不飽和ポリエステル樹脂100部に対し
て、参考例1にて調製した各種ガラス質抗菌剤(試料N
o.1〜No.3)又は抗菌剤組成物(試料No.7〜1
0)を1.0部添加、混合した。硬化剤としてメチルエ
トルケトンパーオキサイド、および硬化促進剤としてナ
フテン酸コバルトを所定量添加し、ゲルコート層作製用
塗料組成物を得た。成型型の内側にスプレーガンにより
塗料組成物を厚さが約0.5mmとなるように塗布し、
室温で硬化させた。引き続き水酸化アルミニウムを50
重量%含有するイソフタル酸系不飽和ポリエステル樹脂
を主成分とする基材樹脂組成物を型内に注入、室温で硬
化、脱型させることにより人工大理石成型体を得た(試
作No.G1〜No.G3、試作No.G7〜G10。但し、試作N
o.GKの人工大理石は試料No.Kのガラス質抗菌剤、抗菌
剤組成物又は抗菌剤を用いて作製したものである(Kは
正の整数)。以下、比較例5において同様に表示し
た)。Example 2 Various vitreous antibacterial agents prepared in Reference Example 1 (sample N) were added to 100 parts of an isophthalic acid-based unsaturated polyester resin.
o.1 to No.3) or an antibacterial agent composition (Sample Nos. 7-1)
1.0) was added and mixed. Predetermined amounts of methyl etoketone peroxide as a curing agent and cobalt naphthenate as a curing accelerator were added to obtain a coating composition for preparing a gel coat layer. Apply the paint composition to the inside of the mold with a spray gun so that the thickness is about 0.5 mm,
Cured at room temperature. Then add 50 parts of aluminum hydroxide
An artificial marble molded product was obtained by injecting a base resin composition containing an isophthalic acid-based unsaturated polyester resin as a main component containing the same by weight into a mold, and curing and demolding at room temperature (Prototype Nos. G1 to No. .G3, Prototype No.G7 to G10, but Prototype N
The o.GK artificial marble was prepared using the glassy antibacterial agent, antibacterial agent composition or antibacterial agent of Sample No. K (K is a positive integer). Hereinafter, it is similarly indicated in Comparative Example 5).
【0052】比較例5 実施例2におけるガラス質抗菌剤又は抗菌剤組成物に代
えて、合成例1で調製した抗菌剤を用いた以外は実施例
2と同様にして抗菌性人工大理石を得た(試作No.G1
1)。Comparative Example 5 An antibacterial artificial marble was obtained in the same manner as in Example 2, except that the antibacterial agent prepared in Synthesis Example 1 was used instead of the vitreous antibacterial agent or the antibacterial agent composition in Example 2. (Prototype No.G1
1).
【0053】比較例6 実施例2におけるガラス質抗菌剤又は抗菌剤組成物に代
えて、合成例2で調製した抗菌剤を用いた以外は実施例
2と同様にして抗菌性人工大理石を得た(試作No.G1
2)。Comparative Example 6 An antibacterial artificial marble was obtained in the same manner as in Example 2 except that the antibacterial agent prepared in Synthesis Example 2 was used instead of the vitreous antibacterial agent or the antibacterial agent composition in Example 2. (Prototype No.G1
2).
【0054】比較例7 抗菌剤を添加しなかったこと以外は実施例2と同様にし
て人工大理石を得た(試作No.G13)。Comparative Example 7 An artificial marble was obtained in the same manner as in Example 2 except that no antibacterial agent was added (prototype No. G13).
【0055】評価試験2 実施例1及び比較例1〜4にて作製した抗菌性人工大理
石について行った方法と同様にして、実施例2、比較例
5〜7にて作製した抗菌性人工大理石について、抗菌
性、耐変色性、耐温水性を評価した。Evaluation Test 2 The antibacterial artificial marble prepared in Example 2 and Comparative Examples 5 to 7 was prepared in the same manner as in the method performed on the antibacterial artificial marble prepared in Example 1 and Comparative Examples 1 to 4. , Antibacterial properties, discoloration resistance and warm water resistance were evaluated.
【0056】[0056]
【表4】 [Table 4]
【0057】本発明におけるガラス質抗菌剤又は抗菌剤
組成物を配合した抗菌性人工大理石(試作No.G1〜G
3、及びG7〜G10)は抗菌性、耐変色性、耐温水性と
も優れた性能を有していることが確認された。一方、
ZnOの含有割合は大きいが、アルカリ金属酸化物の含
有割合が1モル%より大きい抗菌剤用ガラスを配合した
抗菌性プレート(試作No.G4)は、耐変色性に劣り、Z
nOの配合モル比の小さい抗菌剤用ガラスを配合した抗
菌性プレート(試作No.G5)は抗菌性に劣る結果となっ
た。また、ガラス中に亜鉛と共に銀を含有させた抗菌性
プレート(試作No.G6)は耐変色性に劣る結果となっ
た。Antibacterial artificial marble containing the glassy antibacterial agent or the antibacterial agent composition of the present invention (prototype Nos. G1 to G
3, and G7 to G10) were confirmed to have excellent antibacterial properties, resistance to discoloration, and excellent resistance to warm water. on the other hand,
Although the content of ZnO is large, the antibacterial plate (prototype No. G4) containing the glass for antibacterial agents containing alkali metal oxides having a content of more than 1 mol% is inferior in discoloration resistance.
The antibacterial plate (prototype No. G5) containing the antimicrobial agent glass having a small molar ratio of nO was inferior in antibacterial properties. Further, the antibacterial plate containing silver together with zinc in the glass (prototype No. G6) resulted in poor discoloration resistance.
【0058】[0058]
【発明の効果】本発明の抗菌性人工大理石は、加工時、
保存時及び使用時に経時的に変色が極めて少なく、安定
して抗菌効果を示す優れた抗菌性を有している。又、本
発明の抗菌性人工大理石は、耐温水性、及び耐変色性を
も有しており、キッチンカウンター、洗面台、トイレ用
品、バス用品等に用いられる人工大理石として極めて有
用である。The antibacterial artificial marble of the present invention is obtained by
Very little discoloration over time during storage and use, and has excellent antibacterial properties showing stable antibacterial effects. Further, the antibacterial artificial marble of the present invention also has warm water resistance and discoloration resistance, and is extremely useful as an artificial marble used for kitchen counters, wash basins, toilet articles, bath articles and the like.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI //(C04B 26/02 14:22) ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification symbol FI // (C04B 26/02 14:22)
Claims (2)
/またはP2O5を20〜50モル%含有し、アルカリ金
属酸化物の含有割合が0〜1モル%であるガラスを有効
成分とする抗菌剤及び熱硬化性樹脂からなることを特徴
とする抗菌性人工大理石。1. A glass containing 50 to 80 mol% of ZnO, 20 to 50 mol% of B 2 O 3 and / or P 2 O 5, and containing 0 to 1 mol% of an alkali metal oxide. An antibacterial artificial marble comprising an antibacterial agent as an active ingredient and a thermosetting resin.
工大理石において、ゲルコート層が請求項1記載の抗菌
剤及び熱硬化性樹脂からなることを特徴とする抗菌性人
工大理石。2. An artificial marble having a gel coat layer on the surface of a base resin, wherein the gel coat layer comprises the antibacterial agent according to claim 1 and a thermosetting resin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14059198A JP4206513B2 (en) | 1998-05-07 | 1998-05-07 | Antibacterial artificial marble |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14059198A JP4206513B2 (en) | 1998-05-07 | 1998-05-07 | Antibacterial artificial marble |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11314955A true JPH11314955A (en) | 1999-11-16 |
| JP4206513B2 JP4206513B2 (en) | 2009-01-14 |
Family
ID=15272259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14059198A Expired - Lifetime JP4206513B2 (en) | 1998-05-07 | 1998-05-07 | Antibacterial artificial marble |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4206513B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648673A4 (en) * | 2003-07-11 | 2009-01-21 | Cosentino Sa | LIKE NATURAL STONE APPEARING COMPOSITE MATERIAL |
| WO2019150142A1 (en) * | 2018-01-30 | 2019-08-08 | Sanex Pro Kft. | Antimicrobial composite, process for its preparation and its use |
-
1998
- 1998-05-07 JP JP14059198A patent/JP4206513B2/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648673A4 (en) * | 2003-07-11 | 2009-01-21 | Cosentino Sa | LIKE NATURAL STONE APPEARING COMPOSITE MATERIAL |
| WO2019150142A1 (en) * | 2018-01-30 | 2019-08-08 | Sanex Pro Kft. | Antimicrobial composite, process for its preparation and its use |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4206513B2 (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8080490B2 (en) | Antimicrobial phosphate glass | |
| EP1452496B1 (en) | Antibacterial glass composition and antibacterial polymer composition using the same | |
| US20060166806A1 (en) | Antimicrobial sulfophosphate glass | |
| US20050031703A1 (en) | Antimicrobial, water-insoluble silicate glass powder and mixture of glass powders | |
| CN100503497C (en) | Antimicrobial phosphate glass | |
| KR102549169B1 (en) | Antibacterial glass powder and method of manufacturing thereof and domestic appliance including the same | |
| JP3271888B2 (en) | Antibacterial polycarbonate resin products | |
| JP4206513B2 (en) | Antibacterial artificial marble | |
| JP3064753B2 (en) | Method for producing antibacterial thermoplastic resin molding | |
| CN115103821A (en) | Antibacterial glass composition and method for producing same | |
| JP2023554483A (en) | Soluble sterilizing glass and method for preparing soluble sterilizing glass | |
| JP2623117B2 (en) | Unsaturated polyester resin composition | |
| EP4549409B1 (en) | Antibacterial glass composition, method of preparing antibacterial glass powder using the same, and home appliance including the antibacterial glass powder | |
| KR102549391B1 (en) | Antibacterial glass composition and method of manufactruing antibacterial glass powder using the same and domestic appliance including the same | |
| KR102549222B1 (en) | Antibacterial glass composition and method of manufactruing antibacterial glass powder using the same and domestic appliance including the same | |
| JP4368966B2 (en) | Dissolvable glass composition for adding resin moldings having antibacterial properties and resin moldings using the same | |
| KR102867434B1 (en) | Non-elution antibacterial glass composition and method of manufactruing antibacterial glass powder using the same | |
| KR102734357B1 (en) | Heat resistance antibacterial glass composition, method of manufacturing the same and molded product using the same | |
| JPH08188512A (en) | Production of antimicrobial sand | |
| KR102613568B1 (en) | Highly durable antibacterial glass composition, method of manufacturing the same and molded product using the same | |
| JP2841263B2 (en) | Method for producing antibacterial ABS resin molded article | |
| KR20250120963A (en) | Antibacterial glass composition and method for producing antibacterial glass powder thereof, and home appliances comprising the same | |
| KR20250123479A (en) | Antibacterial glass powder and preparing method thereof | |
| JP2000288551A (en) | Prevention of algae | |
| JP2000007514A (en) | Granular antibacterial material and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040806 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070731 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071001 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080924 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20081007 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111031 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111031 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111031 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111031 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121031 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121031 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131031 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |